The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors
- PMID: 16083856
- DOI: 10.1016/j.bbrc.2005.07.092
The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors
Abstract
Osteoclasts are bone resorbing cells of hematopoietic origin. The hematopoietic transcription factor PU.1 is critical for osteoclastogenesis; however, the molecular mechanisms of PU.1-regulated osteoclastogenesis have not been explored. Here, we present evidence that the receptor activator of nuclear factor kappaB (RANK) gene that has been shown to be crucial for osteoclastogenesis is a transcriptional target of PU.1. The PU.1-/- progenitor cells failed to express the RANK gene and reconstitution of PU.1 in these cells induced RANK expression. Treatment of the PU.1 reconstituted cells with M-CSF and RANKL further augmented the RANK gene expression. To explore the regulatory mechanism of the RANK gene expression by PU.1, we have cloned the human RANK promoter. Transient transfection assays have revealed that the 2.2-kb RANK promoter was functional in a monocyte line RAW264.7, whereas co-transfection of PU.1 transactivated the RANK promoter in HeLa cells. Taken together, these results suggest that PU.1 regulates the RANK gene transcription and this may represent one of the key roles of PU.1 in osteoclast differentiation.
Similar articles
-
TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.J Bone Miner Res. 2005 May;20(5):840-7. doi: 10.1359/JBMR.041225. Epub 2004 Dec 20. J Bone Miner Res. 2005. PMID: 15824857
-
NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis.J Cell Biochem. 2003 Oct 1;90(2):424-36. doi: 10.1002/jcb.10625. J Cell Biochem. 2003. PMID: 14505357
-
RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis.Biochem Biophys Res Commun. 1998 Dec 18;253(2):395-400. doi: 10.1006/bbrc.1998.9788. Biochem Biophys Res Commun. 1998. PMID: 9878548
-
Signal transduction pathways regulating osteoclast differentiation and function.J Bone Miner Metab. 2003;21(3):123-33. doi: 10.1007/s007740300021. J Bone Miner Metab. 2003. PMID: 12720046 Review. No abstract available.
-
RANKL-RANK signaling in osteoclastogenesis and bone disease.Trends Mol Med. 2006 Jan;12(1):17-25. doi: 10.1016/j.molmed.2005.11.007. Epub 2005 Dec 13. Trends Mol Med. 2006. PMID: 16356770 Review.
Cited by
-
Regulation of Osteoclast Differentiation and Skeletal Maintenance by Histone Deacetylases.Molecules. 2019 Apr 6;24(7):1355. doi: 10.3390/molecules24071355. Molecules. 2019. PMID: 30959867 Free PMC article. Review.
-
Biomaterial Cues for Regulation of Osteoclast Differentiation and Function in Bone Regeneration.Adv Ther (Weinh). 2025 Jan;8(1):2400296. doi: 10.1002/adtp.202400296. Epub 2024 Nov 15. Adv Ther (Weinh). 2025. PMID: 39867107
-
The origins and roles of osteoclasts in bone development, homeostasis and repair.Development. 2022 Apr 15;149(8):dev199908. doi: 10.1242/dev.199908. Epub 2022 May 3. Development. 2022. PMID: 35502779 Free PMC article. Review.
-
SIRT1 inhibits differentiation of monocytes to macrophages: amelioration of synovial inflammation in rheumatoid arthritis.J Mol Med (Berl). 2016 Aug;94(8):921-31. doi: 10.1007/s00109-016-1402-7. Epub 2016 Mar 9. J Mol Med (Berl). 2016. PMID: 26956118
-
IĸB Protein BCL3 as a Controller of Osteogenesis and Bone Health.Arthritis Rheumatol. 2023 Dec;75(12):2148-2160. doi: 10.1002/art.42639. Epub 2023 Oct 1. Arthritis Rheumatol. 2023. PMID: 37410754 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials